BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 36494582)

  • 1. Glioblastoma glycolytic signature predicts unfavorable prognosis, immunological heterogeneity, and ENO1 promotes microglia M2 polarization and cancer cell malignancy.
    Liang X; Wang Z; Dai Z; Zhang H; Zhang J; Luo P; Liu Z; Liu Z; Yang K; Cheng Q; Zhang M
    Cancer Gene Ther; 2023 Mar; 30(3):481-496. PubMed ID: 36494582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of ATP citrate lyase as a positive regulator of glycolytic function in glioblastomas.
    Beckner ME; Fellows-Mayle W; Zhang Z; Agostino NR; Kant JA; Day BW; Pollack IF
    Int J Cancer; 2010 May; 126(10):2282-95. PubMed ID: 19795461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-intrinsic CD47 signal regulates glycolysis and promotes colorectal cancer cell growth and metastasis.
    Hu T; Liu H; Liang Z; Wang F; Zhou C; Zheng X; Zhang Y; Song Y; Hu J; He X; Xiao J; King RJ; Wu X; Lan P
    Theranostics; 2020; 10(9):4056-4072. PubMed ID: 32226539
    [No Abstract]   [Full Text] [Related]  

  • 4. Enolase 1 regulates stem cell-like properties in gastric cancer cells by stimulating glycolysis.
    Yang T; Shu X; Zhang HW; Sun LX; Yu L; Liu J; Sun LC; Yang ZH; Ran YL
    Cell Death Dis; 2020 Oct; 11(10):870. PubMed ID: 33067426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative stress is involved in immunosuppression and macrophage regulation in glioblastoma.
    Liang X; Wang Z; Dai Z; Liu J; Zhang H; Wen J; Zhang N; Zhang J; Luo P; Liu Z; Liu Z; Cheng Q
    Clin Immunol; 2024 Jan; 258():109802. PubMed ID: 37866784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The type 1 transmembrane glycoprotein B7-H3 interacts with the glycolytic enzyme ENO1 to promote malignancy and glycolysis in HeLa cells.
    Zuo J; Wang B; Long M; Gao Z; Zhang Z; Wang H; Wang X; Li R; Dong K; Zhang H
    FEBS Lett; 2018 Jul; 592(14):2476-2488. PubMed ID: 29924389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WW domain-binding protein 2 acts as an oncogene by modulating the activity of the glycolytic enzyme ENO1 in glioma.
    Chen S; Zhang Y; Wang H; Zeng YY; Li Z; Li ML; Li FF; You J; Zhang ZM; Tzeng CM
    Cell Death Dis; 2018 Mar; 9(3):347. PubMed ID: 29497031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C5aR1-positive neutrophils promote breast cancer glycolysis through WTAP-dependent m6A methylation of ENO1.
    Ou B; Liu Y; Yang X; Xu X; Yan Y; Zhang J
    Cell Death Dis; 2021 Jul; 12(8):737. PubMed ID: 34312368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of POU1F1 promoting the properties of stemness of gastric carcinoma through ENO1-mediated glycolysis reprogramming.
    Tang C; Zhang H; Deng WS; Xiong LQ; Zhou LQ
    Kaohsiung J Med Sci; 2023 Sep; 39(9):904-915. PubMed ID: 37334727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of ENO1 as a prognostic biomarker and molecular target among ENOs in bladder cancer.
    Huang Z; Yan Y; Wang T; Wang Z; Cai J; Cao X; Yang C; Zhang F; Wu G; Shen B
    J Transl Med; 2022 Jul; 20(1):315. PubMed ID: 35836227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular profiling of the tumor microenvironment in glioblastoma patients: correlation of microglia/macrophage polarization state with metalloprotease expression profiles and survival.
    Gjorgjevski M; Hannen R; Carl B; Li Y; Landmann E; Buchholz M; Bartsch JW; Nimsky C
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31142630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enolase 1 stimulates glycolysis to promote chemoresistance in gastric cancer.
    Qian X; Xu W; Xu J; Shi Q; Li J; Weng Y; Jiang Z; Feng L; Wang X; Zhou J; Jin H
    Oncotarget; 2017 Jul; 8(29):47691-47708. PubMed ID: 28548950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A glycolysis-based ten-gene signature correlates with the clinical outcome, molecular subtype and IDH1 mutation in glioblastoma.
    Chen C; Shi Y; Li Y; He ZC; Zhou K; Zhang XN; Yang KD; Wu JR; Kung HF; Ping YF; Bian XW
    J Genet Genomics; 2017 Nov; 44(11):519-530. PubMed ID: 29169920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enolase1 overexpression regulates the growth of gastric cancer cells and predicts poor survival.
    Qiao H; Wang Y; Zhu B; Jiang L; Yuan W; Zhou Y; Guan Q
    J Cell Biochem; 2019 Nov; 120(11):18714-18723. PubMed ID: 31218757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study on the Inhibitory Effect of Curcumin on GBM and Its Potential Mechanism.
    Su X; Chen S; Lu H; Li H; Qin C
    Drug Des Devel Ther; 2021; 15():2769-2781. PubMed ID: 34234410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enolase-1 is a therapeutic target in endometrial carcinoma.
    Zhao M; Fang W; Wang Y; Guo S; Shu L; Wang L; Chen Y; Fu Q; Liu Y; Hua S; Fan Y; Liu Y; Deng X; Luo R; Mei Z; Jiang Q; Liu Z
    Oncotarget; 2015 Jun; 6(17):15610-27. PubMed ID: 25951350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unrevealed roles of extracellular enolase‑1 (ENO1) in promoting glycolysis and pro‑cancer activities in multiple myeloma via hypoxia‑inducible factor 1α.
    Chung IC; Huang WC; Huang YT; Chen ML; Tsai AW; Wu PY; Yuan TT
    Oncol Rep; 2023 Nov; 50(5):. PubMed ID: 37800625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-enolase promotes gastric cancer cell proliferation and metastasis via regulating AKT signaling pathway.
    Sun L; Lu T; Tian K; Zhou D; Yuan J; Wang X; Zhu Z; Wan D; Yao Y; Zhu X; He S
    Eur J Pharmacol; 2019 Feb; 845():8-15. PubMed ID: 30582908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.
    Fu QF; Liu Y; Fan Y; Hua SN; Qu HY; Dong SW; Li RL; Zhao MY; Zhen Y; Yu XL; Chen YY; Luo RC; Li R; Li LB; Deng XJ; Fang WY; Liu Z; Song X
    J Hematol Oncol; 2015 Mar; 8():22. PubMed ID: 25887760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA NMRAL2P promotes glycolysis and reduces ROS in head and neck tumors by interacting with the ENO1 protein and promoting GPX2 transcription.
    Nie Q; Cao H; Yang J; Liu T; Wang B
    PeerJ; 2023; 11():e16140. PubMed ID: 37810778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.